| Renal
failure is a significant cause of morbidity and mortality in the U.S.
Long-term chronic renal replacement therapy with hemodialysis provides
only intermittent filtration function and continues to have unacceptably
high mortality and morbidity rates. Renal transplantation is severely
limited by the shortage of donor organs. Tissue engineering of a renal
replacement device could provide an alternative to hemodialysis or transplant.
We will harvest normal renal cells and use them to construct renal tubules
using bioabsorbable polymers. The bioengineered tubules, along with microfabricated
capillaries will be implanted in vivo to test for replacement renal function.
|